lobbying_activities: 2973713

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2973713	d5c4910e-ad30-4d6d-91d9-5d609a3d100f	Q1	MARSHALL & POPP, LLC	401105121	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2023	first_quarter	PHA	Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169). Issues related to vaccine development and distribution. Issues related to 340B. Issues related to insulin pricing. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including S. 127, Pharmacy Benefit Manager Transparency Act.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2023-04-19T21:31:45-04:00